NCT01343914
Completed
Not Applicable
Retrospective Study to Determinate the Clinical Phenotype of Patients With Non Squamous NSCLC Treated With First Line Bevacizumab-based Therapy That Reached a Long PFS
ConditionsNon-Squamous Non-Small Cell Lung Cancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Non-Squamous Non-Small Cell Lung Cancer
- Sponsor
- Hoffmann-La Roche
- Enrollment
- 118
- Primary Endpoint
- Progression-free survival (>9 months) according to clinical phenotype
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
This retrospective observational study will analyse demographic, clinical and treatment-related data of patients with non-squamous non-small cell lung cancer (NSCLC) who had reached >/= 9 months of progression-free survival after Avastin (bevacizumab)-based first-line therapy. Data will be collected for approximately 9 months.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult patients, \>/= 18 years of age
- •Non-squamous non-small cell lung cancer (NSCLC) treated with first-line Avastin-based therapy
- •Progression-free survival of \>/= 9 months reached
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Progression-free survival (>9 months) according to clinical phenotype
Time Frame: approximately 9 months
Secondary Outcomes
- Safety: Incidence of adverse events(approximately 9 months)
- Overall survival(approximately 9 months)
Similar Trials
Completed
Not Applicable
Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient ProgramChronic Lymphocytic LeukemiaNCT02582320Gruppo Italiano Malattie EMatologiche dell'Adulto264
Unknown
Not Applicable
A Retrospective Study Investigating the Factors Related to Non-tuberculous Mycobacterial Pulmonary Disease in Hong KongNon-Tuberculous Mycobacterial PneumoniaNCT04538898Chinese University of Hong Kong200
Completed
Not Applicable
Study With DapagliflozinDiabetes Mellitus Type 2NCT02971618AstraZeneca929
Completed
Not Applicable
Clinical Determinants of Disease Progression in Patients With Limb Girdle Muscular Distrophy Type 2ELGMD2ENCT04509609Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico33
Completed
Not Applicable
Retrospective Analysis to Describe Patient Profiles, Current Treatment Patterns and Economic Burden for Asthma Patients in UAE. A Descriptive Analysis of the Asthma Patient Population in the Emirate of Dubai With Respect to Healthcare Resource Utilization, Costs, and Asthma-related Treatment PatternAsthmaNCT03963141AstraZeneca40,541